A detailed history of Axa S.A. transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Axa S.A. holds 426,068 shares of MIRM stock, worth $19 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
426,068
Previous 425,992 0.02%
Holding current value
$19 Million
Previous $14.6 Million 14.09%
% of portfolio
0.05%
Previous 0.04%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$33.68 - $44.74 $2,559 - $3,400
76 Added 0.02%
426,068 $16.6 Million
Q2 2024

Aug 14, 2024

SELL
$23.57 - $34.85 $3.95 Million - $5.85 Million
-167,794 Reduced 28.26%
425,992 $14.6 Million
Q1 2024

May 15, 2024

BUY
$24.92 - $30.02 $1,819 - $2,191
73 Added 0.01%
593,786 $14.9 Million
Q4 2023

Jul 16, 2024

SELL
$27.14 - $34.93 $1,981 - $2,549
-73 Reduced 0.01%
593,713 $17.5 Million
Q4 2023

Feb 14, 2024

SELL
$27.14 - $34.93 $635,130 - $817,431
-23,402 Reduced 3.79%
593,713 $17.5 Million
Q3 2023

Nov 14, 2023

SELL
$24.63 - $32.85 $1.27 Million - $1.7 Million
-51,760 Reduced 7.74%
617,115 $19.5 Million
Q2 2023

Aug 14, 2023

SELL
$23.51 - $30.09 $5.16 Million - $6.61 Million
-219,679 Reduced 24.72%
668,875 $17.3 Million
Q1 2023

May 15, 2023

SELL
$19.19 - $24.1 $1.11 Million - $1.4 Million
-57,984 Reduced 6.13%
888,554 $21.3 Million
Q4 2022

Feb 14, 2023

BUY
$17.59 - $23.83 $1.55 Million - $2.1 Million
88,327 Added 10.29%
946,538 $18.5 Million
Q3 2022

Feb 14, 2023

SELL
$19.98 - $29.44 $563,196 - $829,854
-28,188 Reduced 3.18%
858,211 $18 Million
Q3 2022

Nov 14, 2022

SELL
$19.98 - $29.44 $563,196 - $829,854
-28,188 Reduced 3.18%
858,211 $18 Million
Q2 2022

Feb 14, 2023

SELL
$18.42 - $27.5 $1.79 Million - $2.68 Million
-97,430 Reduced 9.9%
886,399 $17.2 Million
Q2 2022

Aug 15, 2022

SELL
$18.42 - $27.5 $1.79 Million - $2.68 Million
-97,430 Reduced 9.9%
886,399 $17.2 Million
Q1 2022

Feb 14, 2023

BUY
$15.5 - $23.93 $1.95 Million - $3.01 Million
125,618 Added 14.64%
983,829 $21.7 Million
Q1 2022

May 13, 2022

SELL
$15.5 - $23.93 $135,253 - $208,813
-8,726 Reduced 0.88%
983,829 $21.7 Million
Q4 2021

Feb 14, 2022

BUY
$13.05 - $19.35 $1.83 Million - $2.72 Million
140,383 Added 16.47%
992,555 $15.8 Million
Q3 2021

Nov 15, 2021

BUY
$13.95 - $20.18 $2.66 Million - $3.85 Million
190,580 Added 28.81%
852,172 $17 Million
Q2 2021

Aug 13, 2021

BUY
$15.84 - $20.6 $1.47 Million - $1.91 Million
92,610 Added 16.28%
661,592 $11.4 Million
Q1 2021

May 14, 2021

BUY
$16.29 - $21.92 $4.29 Million - $5.78 Million
263,496 Added 86.25%
568,982 $11.3 Million
Q4 2020

Feb 12, 2021

BUY
$15.75 - $25.45 $1.22 Million - $1.97 Million
77,496 Added 33.99%
305,486 $5.33 Million
Q3 2020

Nov 13, 2020

BUY
$18.4 - $26.59 $1.12 Million - $1.62 Million
60,950 Added 36.49%
227,990 $4.39 Million
Q2 2020

Aug 14, 2020

BUY
$11.51 - $20.97 $118,426 - $215,760
10,289 Added 6.56%
167,040 $3.25 Million
Q1 2020

May 15, 2020

BUY
$9.38 - $23.79 $1.47 Million - $3.73 Million
156,751 New
156,751 $2.2 Million

Others Institutions Holding MIRM

About Mirum Pharmaceuticals, Inc.


  • Ticker MIRM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,751,700
  • Market Cap $1.64B
  • Description
  • Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...
More about MIRM
Track This Portfolio

Track Axa S.A. Portfolio

Follow Axa S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.